AKRO β€” AKERO THERAPEUTICS INC

Ownership history in KBC Group NV  Β·  4 quarters on record

This page tracks every 13F SEC filing in which KBC Group NV reported a position in AKERO THERAPEUTICS INC (AKRO). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price β€” sourced directly from SEC EDGAR 13F filings.

% of Fund (quarterly)
πŸ“‹ Quarterly Holdings History 4 quarters  β–Ύ
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q2 REDUCED 1,550 -1,421 -47.8% 0.00% $83K β€”
2025 Q1 ADDED 2,971 +1,450 +95.3% 0.00% $120K β€”
2024 Q1 UNCHANGED 1,521 β€” 0% 0.00% $38K β€”
2023 Q4 INITIATED 1,521 β€” β€” 0.00% $36K β€”

🏒 Other funds also holding AKRO

As of 2025 Q4 β€” sorted by position size

Nebula Research & Development LLC 0.07% IFP Advisors, Inc 3Y 7Y 0.0%
← Back to KBC Group NV Holdings